Reding, M. T., Lalezari, S., Kenet, G., Minno, G. D., Ducore, J., Solms, A., . . . Mancuso, M. E. Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationReding, Mark T., et al. Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review. Adis, Springer Healthcare.
MLA (9th ed.) CitationReding, Mark T., et al. Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review. Adis, Springer Healthcare.
Warning: These citations may not always be 100% accurate.